You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 132 No. 12, December 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL REVIEW
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (29)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pulse Glucocorticoid Therapy

The 'Big Shot' Revisited

Jean-Claude Roujeau, MD

Arch Dermatol. 1996;132(12):1499-1502.


Abstract

The very high doses of drugs over a short time. Methylprednisolone (and dexamethasone in some countries) is the glucocorticoid most frequently administered this way. Doses of each pulse are not standardized but are usually 10 to 20 mg per kilogram of body weight for methylprednisolone (250-1000 mg) and 2 to 5 mg per kilogram of body weight (50-200 mg) for dexamethasone. Single doses of 500 mg of methylprednisolone and 100 mg of dexamethasone are both considered equivalent to 625 mg of prednisone.1 These very high doses, sometimes termed megadoses, are usually given as intravenous infusions over 30 minutes to 1 hour daily or every other day for a total of 1 to 5 administrations. In most indications, pulse glucocorticoid therapy is accompanied and/or followed by the continuous administration of lowor intermediate-dose glucocorticoids and/or immunosuppressive agents.



Author Affiliations

From the Service de Dermatologie, Hôpital Henri Mondor, Université Paris XII, Créteil, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Comparison of Oral Methylprednisolone Plus Azathioprine or Mycophenolate Mofetil for the Treatment of Pemphigus.
Beissert et al.
Arch Dermatol 2006;142:1447-1454.
ABSTRACT | FULL TEXT  

Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis
Metselaar et al.
Ann Rheum Dis 2004;63:348-353.
ABSTRACT | FULL TEXT  

Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen et al.
J. Biol. Chem. 2004;279:2135-2146.
ABSTRACT | FULL TEXT  

Potentiation of Vitamin K Antagonists by High-Dose Intravenous Methylprednisolone
Costedoat-Chalumeau et al.
ANN INTERN MED 2000;132:631-635.
ABSTRACT | FULL TEXT  

Therapy of Pemphigus Vulgaris
Stanley
Arch Dermatol 1999;135:76-78.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.